(a) By guideline, the department shall establish a system, sufficient for the purposes of subsections (b) and (c) of this section, to collect data from the local health officers, from public and private health care providers and from parents on the incidence of pertussis and major adverse reactions to pertussis vaccine.
(b) On the basis of information collected under this subsection and of other information available, the department shall periodically revise and update the information required by and the guidelines adopted under 16-3B-2 of this code.
(c) The department shall report to the United States Centers for Disease Control and Prevention all information collected under this section, including that received under 16-3B-3 of this code.